AveXis expands gene therapy manufacturing facility in North Carolina with additional $60M investment

AveXis, a Novartis company, announced an additional $60 million investment and 200 new jobs at its gene therapy manufacturing site in Durham, North Carolina, bringing total investment to $115 million and planned employment to 400. The facility is expected to be completed in the second half of 2020.

“Continued investment in our infrastructure in North Carolina will allow us to manufacture multiple gene therapies simultaneously, helping us reach more patients, faster.”fiercepharma.com

• 1 source
• fiercepharma.comNovartis’ AveXis doubles down with $115M manufacturing investment | Fierce PharmaEric PalmerFeb 19, 2019

Summarized from public sources; check the original articles before acting on it.